Brief: Pharmena Raises Share Capital In Cortria Corporation

Pharmena SA

29/05/2018 10:51

May 29 (Reuters) - PHARMENA SA  PHR.WA :
    * HAS INCREASED THE SHARE CAPITAL OF CORTRIA CORPORATION BY
USD
0.2 MLN
    * ACCORDING TO THE MANAGEMENT, THE INCREASED CAPITAL WILL
ENABLE
TO COVER CURRENT OPERATIONAL EXPENSES OF THE UNIT WHAT IN TURN
WILL INCREASE THE CHANCE OF THE COMMERCIALISATION OF ITS
ARTERIOSCLEROSIS DRUG 
    * SAYS POTENTIAL REVENUES FROM THE COMMERCIALISATION OF THE
DRUG
MIGHT HAVE A "SIGNIFICANT" IMPACT ON THE FINANCIAL AND ECONOMIC
SITUATION OF THE COMPANY CAPITAL GROUP
    * CORTRIA CORPORATION, PHARMENA'S UNIT, IS A PHARMACEUTICAL
COMPANY WHICH DEVELOPS MEDICINES FOR THE TREATMENT OF
CARDIOVASCULAR DISEASES

    
 Source text for Eikon: urn:newsml:reuters.com:*:nEB5FvFK1
    
 Further company coverage:  PHR.WA  
   


 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))